Uh oh! Wolfram|Alpha doesn't run without JavaScript.
Please enable JavaScript. If you don't know how, you can find instructions
here
.
Once you've done that, refresh this page to start using Wolfram|Alpha.
JPM26: AbbVie pays $650M upfront for rights to RemeGen's PD-1/VEGF bispecific - FirstWord
JPM26: AbbVie pays $650M upfront for rights to RemeGen's PD-1/VEGF bispecific - FirstWord
Natural Language
Math Input
Extended Keyboard
Examples
Upload
Random
